Adam Aaron Goldblum

This inventor holds 47 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Antibacterial Compounds. Top assignees: Theravance, Inc., Achaogen, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Aaron Goldblum. Retrieved from https://idiyas.com/inventor/adam-aaron-goldblum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 (Patent Applications = 6)

% Patents Active = 78.7

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 10

Forward Citations = 302(Granted Patents)

Location History:

San Francisco, CA (US) (2008 - 2012)
Emeryville, CA (US) (2015 - 2018)
Berkeley, CA (US) (2008 - 2021)
Warren, NJ (US) (2022)

Company Filing History:

Theravance Biopharma R&d IP, LLC

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Aminoglycoside

Quinolinone

Carboxamide

5-HT4 Agonist

Antibacterial

Crystalline Form

Indazole

Benzoimidazolone

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12122769 - Synthesis of antibacterial aminoglycoside analogs (2024-10-22),

2. 11453658 - Synthesis of antibacterial aminoglycoside analogs (2022-09-27),

3. 11117915 - Antibacterial aminoglycoside analogs (2021-09-14),

4. RE47741 - Antibacterial aminoglycoside analogs (2019-11-25),

5. 9873692 - Quinolinone-carboxamide compounds as 5-HT4 receptor agonists (2018-01-23),

6. 9688711 - Antibacterial aminoglycoside analogs (2017-06-27),

7. 9630960 - Quinolinone-carboxamide compounds as 5-HT4 receptor agonists (2017-04-25),

8. 9402840 - Crystalline form of a quinolinone-carboxamide compound (2016-08-02),

9. 9353106 - Quinolinone-carboxamide compounds as 5-HT4 receptor agonists (2016-05-31),

10. 9266919 - Antibacterial aminoglycoside analogs (2016-02-23),

11. 9126994 - Crystalline form of a quinolinone-carboxamide compound (2015-09-08),

12. 8962653 - [object Object] (2015-02-24),

13. 8822424 - Antibacterial aminoglycoside analogs (2014-09-02),

14. 8658671 - Crystalline form of a quinolinone-carboxamide compound (2014-02-25),

15. 8658606 - Antibacterial aminoglycoside analogs (2014-02-25),

Title: The Innovative Mind of Adam Aaron Goldblum

Introduction: Adam Aaron Goldblum is a renowned inventor based in Berkeley, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Adam Aaron Goldblum holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Adam Aaron Goldblum has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Adam Aaron Goldblum has collaborated with top universities, innovative companies, and talented individuals to bring his ideas to life and make a lasting impact on society.

Conclusion: Adam Aaron Goldblum's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.